Compound Passport Service: supporting corporate collection owners in open innovation

Drug Discovery Today

Volumn 20, Issue 10, 2015, Pages 1250-1255

  Andrews, David M ^a   Degorce, Sébastien L ^a   Drake, David J ^a   Gustafsson, Magnus ^b   Higgins, Kevin M ^a   Winter, Jon J ^a  

^a ASTRAZENECA   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPOUND PASSPORT SERVICE; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG RESEARCH; HEALTH SERVICE; MEDICINAL CHEMISTRY; PATENT; REVIEW; RISK MANAGEMENT; COOPERATION; DRUG DATABASE; HUMAN; ORGANIZATION AND MANAGEMENT; PROCEDURES; SOCIAL MEDIA;

CHEMISTRY, PHARMACEUTICAL; COOPERATIVE BEHAVIOR; DATABASES, PHARMACEUTICAL; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; OWNERSHIP; SOCIAL MEDIA;

EID: 84944441004     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.06.011     Document Type: Review

References (23)

1. S.M. Paul, and et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat. Rev. Drug Discov. 9 2010 203 221
2. C. Ganellin Historical approaches to drug discovery Ars Pharm. 36 1995 329 335
3. J.L. LaMattina The impact of mergers on pharmaceutical R&D Nat. Rev. Drug Discov. 10 2011 559 560
4. W.L. Jorgensen Challenges for academic drug discovery Angew. Chem. Int. Ed. 51 2012 11680 11684
5. H.W. Chesbrough Open Innovation: The New Imperative for Creating and Profiting from Technology 2003 Harvard Business School Press
6. R. Pigott, and et al. Shaping the Future of Open Innovation: A Practical Guide for Life Sciences Organisations 2014 Available at: http://www.wellcome.ac.uk/About-us/Publications/Reports/Biomedical-science/ (accessed 28.03,15)
7. K. Krämer Crossing the valley of death Chem. World 12 2015 49 51
8. T. Kogej, and et al. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case Drug Discov. Today 18 2013 1014 1024
9. D.M. Andrews, and et al. Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface Drug Discov. Today 19 2014 496 501
10. A.M. Jordan, and et al. Rethinking 'academic' drug discovery: the Manchester Institute perspective Drug Discov. Today 20 2015 525 535
11. A.T. Plowright, and et al. Hypothesis driven drug design: improving quality and effectiveness of the design-make-test-analyse cycle Drug Discov. Today 17 2012 56 62
12. Service oriented architecture: what is SOA? In: The SOA Source Book. Available at: http://www.opengroup.org/soa/source-book/soa/soa.htm (accessed 28.03.15)
13. A. Mullard European lead factory opens for business Nat. Rev. Drug Discov. 12 2013 173 175
14. N.P. Jones, and A. Schulze Targeting cancer metabolism - aiming at a tumour's sweet-spot Drug Discov. Today 17 2012 232 241
15. L. Osherovich AstraZeneca's compound interest SciBX 5 2012 10.1038/scibx.2012.2
16. Available at: http://openinnovation.astrazeneca.com/ (accessed 28.03.15)
17. T. Melese, and et al. Open innovation networks between academia and industry: an imperative for breakthrough therapies Nat. Med. 15 2009 502 507
18. Available at: http://www.enterprisetech.com/2014/07/10/aws-talks-enterprise-wins-adds-zocalo-collaboration/ (accessed 28.03.15)
19. A. Bhardwaj, and et al. Collaborative tools to accelerate neglected disease research: open-source drug discovery model S. Ekins, Collaborative Computational Technologies for Biomedical Research 2011 John Wiley & Sons 321 334
20. S. Ekins, and et al. Pioneering use of the cloud for development of collaborative drug discovery (CDD) database S. Ekins, Collaborative Computational Technologies for Biomedical Research 2011 John Wiley & Sons 335 361
21. B.H. Hall, and et al. A Study of Patent Thickets 2013 Available at: https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/311234/ipresearch-thickets.pdf (accessed 28.03.15)
22. W. Wesley Hill Open innovation's answer to the challenges of patent overpropertization J. Intellect. Prop. Law Pract. 9 2014 730
23. G. Papadatos, and J.P. Overington The ChEMBL database: a taster for medicinal chemists Future Med. Chem. 6 2014 361 364